Equity

9 Months Ended

Sep. 30, 2024

Equity

Equity

8. Equity 

Preferred Stock

The Company has authorized a total of 10,000,000 shares of preferred stock, par value $0.01 per share. As of September 30, 2024, the Company had issued 713,750 shares of Series D Convertible Preferred Stock. The Company’s Board of Directors has the authority to provide, out of the unissued shares of preferred stock, for one or more series of ,026preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

Common Stock

As of September 30, 2024 and 2023, respectively, the Company had authorized 500,000,000 shares of its common stock, par value $0.001 per share. As of September 30, 2024, the Company had 211,101,313 shares issued and 172,913,813 shares outstanding.

Shares to be Issued

As of September 30, 2024 and December 31, 2023, the Company had 5,476,967 shares to be issued.

Treasury Stock

As of September 30, 2024 and December 31, 2023, the Company had 38,187,500 treasury stock issued and outstanding.